Global Polymerase Chain Reaction Market 2021

January 2022 | 15 pages | ID: GA7AAC819CBFEN
StrategyHelix Inc

Abstracts

Polymerase chain reaction (PCR) is a laboratory technique used to amplify DNA sequences. The technique can produce a billion copies of the target sequence in just a few hours. Once amplified, the DNA produced by PCR can be used in many different laboratory procedures. PCR is also valuable in a number of laboratory and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses (particularly AIDS), and diagnosis of genetic disorders. The global polymerase chain reaction market is poised to grow by US$ 3,858 million during 2021-2027, progressing at a CAGR of 6.1% during the forecast period, according to data and analytics company StrategyHelix. Rise in prevalence of infectious diseases and cancer, increase in awareness and acceptance of personalized medicines, rapid increase in geriatric population, rise in disposable income in developing economies are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for polymerase chain reaction. The global polymerase chain reaction market is segmented on the basis of product, technology, application, and region. By product, the global polymerase chain reaction market has been segmented into reagents & consumables, instruments, software, services. According to the research, the reagents & consumables segment had the largest share in the global polymerase chain reaction market. Based upon technology, the global polymerase chain reaction market is categorized into real-time PCR, inverse PCR, assembly & nested PCR, multiplex PCR, reverse transcriptase PCR, others. On the basis of application, the global polymerase chain reaction market has been segmented into research, clinical, others. Geographically, the global polymerase chain reaction market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global polymerase chain reaction market is highly competitive. The prominent players operating in the global polymerase chain reaction market include Abbott Laboratories, Becton Dickinson and Company, BioFire Diagnostics LLC, Bio-Rad Laboratories Inc., Eppendorf AG, F. Hoffmann-LaRoche Ltd., GE Healthcare, Hologic Inc., Merck KGaA (Sigma-Aldrich), QIAGEN N.V., Thermo Fisher Scientific Inc.

Report Scope
Product: reagents & consumables, instruments, software, services
Technology: real-time PCR, inverse PCR, assembly & nested PCR, multiplex PCR, reverse transcriptase PCR, others
Application: research, clinical, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global polymerase chain reaction market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. POLYMERASE CHAIN REACTION MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY PRODUCT

Reagents & consumables
Instruments
Software
Services

PART 4. MARKET BREAKDOWN BY TECHNOLOGY

Real-time PCR
Inverse PCR
Assembly & nested PCR
Multiplex PCR
Reverse transcriptase PCR
Others

PART 5. MARKET BREAKDOWN BY APPLICATION

Research
Clinical
Others

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

Abbott Laboratories
Becton, Dickinson and Company
BioFire Diagnostics LLC
Bio-Rad Laboratories Inc.
Eppendorf AG
F. Hoffmann-LaRoche Ltd.
GE Healthcare
Hologic Inc.
Merck KGaA (Sigma-Aldrich)
QIAGEN N.V.
Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer